23andMe Stock Could Be a Big Winner If This 1 Thing Happens
In June, 23andMe (NASDAQ: ME) officially finished the process of going public via a special purpose acquisition company (SPAC). These investment vehicles were popular in early 2021, but many have lost value in recent months. This includes 23andMe stock, which currently sits almost 50% below its all-time high.
While no one knows where shares of the genetic-testing company will trade in the near term, investors have a better idea of where 23andMe stock can trade over the long term. Over the course of years, stock prices tend to correlate with cash flows and, therefore, if the company dramatically increases it cash flows, the stock price could head higher as well. And in this video from Motley Fool Backstage Pass, recorded on Oct. 5, Fool contributor Jason Hall explains to fellow contributor Jon Quast the one thing that could transform 23andMe's cash flows.
Source Fool.com
